Additional price cuts in nationwide expansion of China’s centralized procurement

China’s Joint Procurement Office announced steep price cuts for companies that won the tender bids for 25 drugs in the nationwide expansion of its pilot program for centralized procurement of generic and off-patent originator drugs.

In December, winning bidders in the pilot agreed to average price cuts of 52%, with discounts as high as 90% for the antiviral entecavir (see “China Releases Final Results of Centralized Procurement Bids”)...